发明名称 |
Vandetanib derivatives |
摘要 |
This invention relates to novel quinazoline derivatives of the formula: wherein each variable is as defined herein, and their acceptable acid addition salts. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by inhibitory activity against the VEGF receptor tyrosine kinase. |
申请公布号 |
US8609673(B2) |
申请公布日期 |
2013.12.17 |
申请号 |
US20090864219 |
申请日期 |
2009.01.22 |
申请人 |
TUNG ROGER;CONCERT PHARMACEUTICALS, INC. |
发明人 |
TUNG ROGER |
分类号 |
A61K31/517;A61P13/12;A61P17/06;A61P29/00;A61P35/00;C07D239/84 |
主分类号 |
A61K31/517 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|